St. Charles, Missouri Clinical Trials

*Healthy Patient Studies

Pharma Medica Research, INC

Healthy, Post-Menopausal Females

Pharma Medica Research, INC

Pharma Medica Research, INC is seeking Healthy participants for a research study.

Asthma

Midwest Chest Consultants

Phase III, randomized, double-blind, active-controlled, parallel-group study, comparing the efficacy, safety and tolerability of the fixed dose combination of FF/UMEC/VI with the fixed dose dual combination of FF/VI, administered once-daily via a dry powder inhaler in subjects with inadequately controlled ASTHMA.

View More »

GSK Investigational Site Updated

A clinical trial to evaluate treatments for patients with Asthma

Attention Deficit/Hyperactivity Disorder (ADHD - Adults)

Midwest Research Group

Patients are needed to participate in a clinical research study evaluating EVO for the treatment of Attention Deficit Disorder With Hyperactivity

Midwest Research Group Updated

A clinical trial to evaluate treatments using EVO for patients with Attention Deficit Disorder With Hyperactivity

St. Charles Psychiatric Associates Midwest Research Center

A clinical trial seeking patients for a research study for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) (CHIME 2)

Autism

St. Charles Psychiatric Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Binge Eating Disorder

Midwest Research Group - St. Charles Psychiatric Associates

A clinical trial to evaluate treatments using dasotraline 4mg, dasotraline 6mg and Placebo for patients with Binge Eating Disorder

Bipolar Disorder

Investigative Site 011

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

St. Charles Psychiatric Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism

Bulimia

Midwest Research Group - St. Charles Psychiatric Associates

A clinical trial to evaluate treatments using dasotraline 4mg, dasotraline 6mg and Placebo for patients with Binge Eating Disorder

Chronic Obstructive Lung Disease

Midwest Chest Consultants, PC

A Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase IV Study to Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and COPD Exacerbations in Patients with Monderate

COPD (Chronic Obstructive Pulmonary Disease)

Midwest Chest Consultants

A 24-week treatment, multi-center, randomized, double-blind, double-dummy, parallel group study to compare Umeclidinium/Vilanterol, Umeclidinium, and Salmeterol in subjects with chronic obstructive pulmonary disease (COPD)

Midwest Chest Consultants

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).

Midwest Chest Consultants, PC

Midwest Chest Consultants, located in St. Charles Missouri, is currently conducting a research study with individuals with Chronic Obstructive Pulmonary Disease (COPD).

View More »

Pearl Investigative Site

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Pearl Investigative Site

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Depression

MMG

Does Your Child Have Depression?

View More »

Forest Investigative Site 040

A clinical research study of Vilazodone, Placebo and Fluoxetine for the treatment of Major Depressive Disorder

Investigative Site 011

Patients are needed to participate in a clinical research study of cariprazine and placebo to evaluate Bipolar Disorder or Depression

Investigative Site 040

A clinical research study of Vilazodone for the treatment of Major Depressive Disorder

St. Charles Psychiatric Associates - Midwest Research Group Updated

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

St. Charles Psychiatric Associates - Midwest Research Group Updated

Patients are needed to participate in a clinical research study of Rapastinel and Placebo to evaluate Depressive Disorder, Major

US1266

A clinical trial seeking patients for a research study for the treatment of Depressive Disorder, Major

US1266

Patients are needed to participate in a clinical research study of Vortioxetine 10 mg/day, Vortioxetine 20 mg/day, Fluoxetine 20mg/day and Placebo to evaluate Depressive Disorder, Major

Depression (Adolescent)

MMG

Does Your Child Have Depression?

Depression (Major/Severe)

MMG

Does Your Child Have Depression?

Heart Failure

Research Site Updated

A clinical study for patients with Heart Failure

Lung Disease

Pearl Investigative Site

Patients are needed to participate in a clinical research study evaluating BGF MDI (PT010) 320/14.4/9.6 μg, GFF MDI (PT003) 14.4/9.6 μg and BFF MDI (PT009) 320/9.6 μg for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disorder

Schizophrenia and Schizoaffective Disorders

Center Pointe Hospital

A clinical research study of SEP-363856 and Placebo - Cap for the treatment of Schizophrenia

St. Charles Psychiatric Associates

Patients are needed to participate in a clinical research study of Lurasidone 20, 40, 60, 80 mg, flexibly dosed to evaluate Schizophrenia or Austism